Mares J, Claesson-Welsh L, Welsh M
Department of Medical Cell Biology, Uppsala University, Sweden.
Growth Factors. 1992;6(2):93-101. doi: 10.3109/08977199209011013.
This study was undertaken to characterize the expression of a chimeric growth factor receptor composed of the extracellular and transmembrane domains of the platelet-derived growth factor (PDGF) beta-receptor (PDGFR-beta) fused to the intracellular domain of the fibroblast growth factor receptor-1 (FGFR-1) and to assess its effect on the growth potential of pancreatic islet cells. For this purpose rat pancreatic islets or monolayers of pancreatic islet cells were transfected with recombinant DNA constructs coding for the PDGF B-chain, the PDGFR-beta, the FGFR-1 and the chimera between PDGFR-beta and FGFR-1. DNA synthesis, monitored as the percentage of labelled nuclei and [3H]thymidine incorporation, was stimulated in pancreatic islet cells cotransfected with the constructs coding for the PDGF B-chain and the PDGFR-beta or the chimeric PDGFR-beta/FGFR-1 as compared with that determined after transfection with control plasmid. PDGF-BB stimulated DNA synthesis when islet cells had been transfected with PDGFR-beta or PDGFR-beta/FGFR-1. Cotransfection of the PDGFR-beta and the chimeric PDGFR-beta/FGFR-1 constructs attenuated the stimulation of DNA synthesis in response to PDGF-BB. Receptor binding studies showed binding with a Kd of 0.7 nM to the chimeric receptor. The present findings show that when the chimeric PDGFR-beta/FGFR-1 construct is expressed in beta-cells it is efficient in increasing DNA synthesis when stimulated with ligand.
本研究旨在表征一种嵌合生长因子受体的表达,该受体由血小板衍生生长因子(PDGF)β受体(PDGFR-β)的细胞外和跨膜结构域与成纤维细胞生长因子受体-1(FGFR-1)的细胞内结构域融合而成,并评估其对胰岛细胞生长潜能的影响。为此,用编码PDGF B链、PDGFR-β、FGFR-1以及PDGFR-β与FGFR-1之间嵌合体的重组DNA构建体转染大鼠胰岛或胰岛细胞单层。与用对照质粒转染后测定的结果相比,在用编码PDGF B链和PDGFR-β或嵌合PDGFR-β/FGFR-1的构建体共转染的胰岛细胞中,以标记细胞核的百分比和[3H]胸苷掺入量监测的DNA合成受到刺激。当胰岛细胞用PDGFR-β或PDGFR-β/FGFR-1转染时,PDGF-BB刺激DNA合成。PDGFR-β和嵌合PDGFR-β/FGFR-1构建体的共转染减弱了对PDGF-BB的DNA合成刺激。受体结合研究表明,与嵌合受体的结合Kd为0.7 nM。目前的研究结果表明,当嵌合PDGFR-β/FGFR-1构建体在β细胞中表达时,用配体刺激可有效增加DNA合成。